Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.

Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.

Item
http://www.wikidata.org/entity/Q27853117
CIViC databaseTherapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosisA high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma.Internal Auditory Canal Decompression for Hearing Maintenance in Neurofibromatosis Type 2 Patients.Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macroMechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2.Looking for the needle in the haystack: Proteome-based identification of treatment targets in NF2-related nervous system tumors.Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas.A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas.An update on the diagnosis and treatment of vestibular schwannoma.Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.Emerging Medical Treatments for Meningioma in the Molecular Era
P2860

Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.

Item
http://www.wikidata.org/entity/Q27853117
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@ast
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@en
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@nl
type
label
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@ast
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@en
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@nl
prefLabel
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@ast
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@en
Phase II study of mTORC1 inhib ...... rowing vestibular schwannomas.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P356
P1433
P1476
Phase II study of mTORC1 inhib ...... growing vestibular schwannomas
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698